This 8-hour, online course will provide an overview of the basics of addiction medicine needed to screen, diagnose, treat and/or refer patients with addiction

This one-hour, journal article-based activity examines the efficacy and safety of methylphenidate (MPH) for the treatment of cocaine use disorder (CUD). Learners will explore findings from a systematic review and meta-analysis evaluating the effects of MPH on cocaine craving and use, including differences in outcomes among individuals with and without co-occurring attention-deficit/hyperactivity disorder (ADHD). The article also examines factors that may influence treatment outcomes, considerations related to the safety of MPH, and limitations in the current evidence base to inform future research and clinical practice.

This one-hour, journal article-based activity examines the efficacy and safety of pharmacological interventions for electronic cigarette cessation. Learners will explore current evidence for varenicline, nicotine replacement therapy (NRT), and cytisine, including their effects on abstinence and reported adverse events. The article also examines current limitations in the evidence base and considerations for applying pharmacological approaches to support adults seeking to stop using electronic cigarettes.

This one-hour, journal article-based activity examines ongoing clinical trials for cocaine use disorder (CUD) and evaluates how well ongoing studies align with recent Food and Drug Administration (FDA) recommendations. Learners will explore trends in trial design, including the use of pharmacologic, behavioral, device-based, and digital interventions, while examining common strengths and gaps in current research. The activity also discusses how adherence to regulatory guidance may influence the development, evaluation, and future implementation of effective treatments for CUD.

This 88-hour on-demand conference includes 75 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 60-minute on-demand session from the ASAM 57th Annual Conference addresses long-acting injectable buprenorphine implementation in criminal justice settings, exploring evidence, challenges, and program development strategies.

This 75-minute on-demand session from the ASAM 57th Annual Conference addresses novel kratom-derived products including 7-OH and kava, covering pharmacology, clinical assessment, and evolving regulatory landscapes.

This 1 hour and 45-minute on-demand session from the ASAM 57th Annual Conference addresses benzodiazepine management in outpatient settings, applying ASAM guidelines to cases and exploring tapering strategies and success definitions.

This 75-minute on-demand session from the ASAM 57th Annual Conference addresses substance use disorders in transplant candidates and recipients, covering evaluation approaches, multidisciplinary care, and long-term outcome strategies.

This 75-minute on-demand session from the ASAM 57th Annual Conference addresses medication call backs in MOUD programs, balancing diversion control strategies with patient-centered and equitable treatment access approaches.